IRINA SELIVERSTOV: Open Payments
NPI 1386646099 · LYNN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 20 payments from 11 companies in 2025. Trend: 2023 $665 · 2024 $791 · 2025 $1,008
Food & beverage: $1,008
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $257 |
| Eisai Inc. | 3 | $151 |
| Madrigal Pharmaceuticals | 1 | $139 |
| Phathom Pharmaceuticals, Inc. | 1 | $118 |
| GlaxoSmithKline, LLC. | 1 | $103 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $58 |
| Lilly USA, LLC | 3 | $49 |
| Novo Nordisk Inc | 2 | $36 |
| Exact Sciences Corporation | 1 | $17 |
Products named: Leqembi, REZDIFFRA, Yeztugo, Epclusa, VOQUEZNA, JARDIANCE, MOUNJARO, FARXIGA.
Industry payments across MA — which companies pay providers there.
